PATRICK J. LORD - 11 Mar 2024 Form 4 Insider Report for LAM RESEARCH CORP (LRCX)

Signature
Marta Woods by Power of Attorney
Issuer symbol
LRCX
Transactions as of
11 Mar 2024
Net transactions value
-$1,847,767
Form type
4
Filing time
13 Mar 2024, 16:39:39 UTC
Previous filing
05 Mar 2024
Next filing
30 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRCX Common Stock Options Exercise $815,579 +1,362 +17% $598.81 9,328 11 Mar 2024 Direct F1, F2
transaction LRCX Common Stock Sale $277,404 -300 -3.2% $924.68 9,028 11 Mar 2024 Direct F1, F2, F3
transaction LRCX Common Stock Sale $297,175 -321 -3.6% $925.78 8,707 11 Mar 2024 Direct F1, F2, F4
transaction LRCX Common Stock Sale $248,436 -268 -3.1% $927.00 8,439 11 Mar 2024 Direct F1, F2, F5
transaction LRCX Common Stock Sale $112,300 -121 -1.4% $928.10 8,318 11 Mar 2024 Direct F1, F2, F6
transaction LRCX Common Stock Sale $114,298 -123 -1.5% $929.25 8,195 11 Mar 2024 Direct F1, F2, F7
transaction LRCX Common Stock Sale $94,004 -101 -1.2% $930.73 8,094 11 Mar 2024 Direct F1, F2, F8
transaction LRCX Common Stock Sale $93,332 -100 -1.2% $933.32 7,994 11 Mar 2024 Direct F1, F2
transaction LRCX Common Stock Sale $26,318 -28 -0.35% $939.93 7,966 11 Mar 2024 Direct F1, F2
transaction LRCX Common Stock Options Exercise $1,095,195 +2,026 +25% $540.57 9,992 11 Mar 2024 Direct F1, F2
transaction LRCX Common Stock Sale $277,278 -300 -3% $924.26 9,692 11 Mar 2024 Direct F1, F2, F9
transaction LRCX Common Stock Sale $185,058 -200 -2.1% $925.29 9,492 11 Mar 2024 Direct F1, F2, F10
transaction LRCX Common Stock Sale $305,570 -330 -3.5% $925.97 9,162 11 Mar 2024 Direct F1, F2, F11
transaction LRCX Common Stock Sale $301,554 -325 -3.5% $927.86 8,837 11 Mar 2024 Direct F1, F2, F12
transaction LRCX Common Stock Sale $434,137 -467 -5.3% $929.63 8,370 11 Mar 2024 Direct F1, F2, F13
transaction LRCX Common Stock Sale $189,855 -204 -2.4% $930.66 8,166 11 Mar 2024 Direct F1, F2, F14
transaction LRCX Common Stock Sale $163,482 -175 -2.1% $934.18 7,991 11 Mar 2024 Direct F1, F2, F15
transaction LRCX Common Stock Sale $23,462 -25 -0.31% $938.50 7,966 11 Mar 2024 Direct F1, F2
transaction LRCX Common Stock Options Exercise $690,724 +1,407 +18% $490.92 9,373 11 Mar 2024 Direct F1, F2
transaction LRCX Common Stock Sale $328,155 -355 -3.8% $924.38 9,018 11 Mar 2024 Direct F1, F2, F16
transaction LRCX Common Stock Sale $74,027 -80 -0.89% $925.34 8,938 11 Mar 2024 Direct F1, F2
transaction LRCX Common Stock Sale $222,401 -240 -2.7% $926.67 8,698 11 Mar 2024 Direct F1, F2, F17
transaction LRCX Common Stock Sale $284,164 -306 -3.5% $928.64 8,392 11 Mar 2024 Direct F1, F2, F18
transaction LRCX Common Stock Sale $148,739 -160 -1.9% $929.62 8,232 11 Mar 2024 Direct F1, F2, F13
transaction LRCX Common Stock Sale $58,632 -63 -0.77% $930.67 8,169 11 Mar 2024 Direct F1, F2, F19
transaction LRCX Common Stock Sale $98,810 -106 -1.3% $932.17 8,063 11 Mar 2024 Direct F1, F2, F20
transaction LRCX Common Stock Sale $74,719 -80 -0.99% $933.99 7,983 11 Mar 2024 Direct F1, F2
transaction LRCX Common Stock Sale $15,954 -17 -0.21% $938.50 7,966 11 Mar 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise $0 -1,362 -100% $0.000000* 0 11 Mar 2024 Common Stock 1,362 $598.81 Direct F1, F21
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise $0 -2,026 -67% $0.000000 1,013 11 Mar 2024 Common Stock 2,026 $540.57 Direct F1, F22
transaction LRCX Employee Stock Option (Right to Buy) Options Exercise $0 -1,407 -33% $0.000000 2,814 11 Mar 2024 Common Stock 1,407 $490.92 Direct F1, F23
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 27, 2023.
F2 The amount reported includes shares subject to unvested restricted stock units.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $924.27 to $924.98, inclusive.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $925.43 to $926.26, inclusive.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $926.70 to $927.70, inclusive.
F6 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $927.85 to $928.36, inclusive.
F7 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $929.03 to $929.85, inclusive.
F8 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $930.46 to $931.22, inclusive.
F9 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $923.95 to $924.43, inclusive.
F10 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $925.09 to $925.49, inclusive.
F11 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $925.62 to $926.47, inclusive.
F12 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $927.26 to $928.20, inclusive.
F13 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $929.23 to $930.00, inclusive.
F14 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $930.47 to $930.85, inclusive.
F15 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $934.05 to $934.35, inclusive.
F16 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $923.79 to $924.71, inclusive.
F17 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $926.47 to $927.02, inclusive.
F18 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $928.21 to $929.05, inclusive.
F19 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $930.30 to $930.98, inclusive.
F20 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $931.70 to $932.32, inclusive.
F21 The stock options will become exercisable in three equal installments on 3/1/2022, 03/1/2023, and 3/2/2024.
F22 The stock options will become exercisable in three equal installments on 3/1/2023, 03/1/2024, and 3/2/2025
F23 The stock options will become exercisable in three equal installments on 03/01/2024, 03/01/2025, and 03/01/2026.

Remarks:

This is form one of two forms, to report the 10b5-1 transactions dated March 11, 2024.